Latest genetic mutation News | Page 5

AstraZeneca expands global footprint in rare disease with availability of first Alexion rare disease therapy for patients
New Technique Helps ID Genes Related to Aging
New melanoma breakthrough by Australian company could potentially save thousands of lives
Biomedical wonders brought to life in Art of Science exhibition
Corrupt endothelial cells protect blood cancer cells from chemotherapy
Gene mutations should be tested routinely for ovarian cancer, say scientists
Blood cancer scientists developing powerful new tools to improve diagnosis and treatment for patients
Danicopan add-on to Ultomiris or Soliris met primary endpoint
Vaccine Expected to Induce Strong Immune Responses Against 2022 Monkeypox Virus, Research Shows
Link between disrupted enzyme and intellectual disability revealed
Corals pass mutations acquired during their lifetimes to offspring
Using mathematics to treat malaria
New AI platform for people with genetic disorders
Eplontersen met co-primary and secondary endpoints in interim analysis of NEURO-TTRansform Phase III trial for hereditary
Cell biology discovery opens doors for brain disease research
Australian Discovery in Sudden Cardiac Arrest Could Save Lives
Queensland researchers target new treatments for childhood dementia
Living with rare genetic disorder
Researcher reveals new insights on link between genetic mutations and biological evolution
Kathleen Megan Folbigg: statement by Attorney General Mark Speakman
Following cancer’s status updates: University of Melbourne
Genetic strength in numbers
Will Australia be left behind in cancer genomics revolution?
Some autism spectrum disorder symptoms linked to astrocytes
Genetics affects functions of gut microbiome
CRISPR gene editing reveals biological mechanism behind common blood disorder
NCI-COG Pediatric MATCH study shows benefit of genetic screening in refractory tumors
Victorian Biobank Now Globally Recognised
Researchers find surprising twist behind rare neurological disorder
Study shows long-term safety of genetically modified immune effector cells
Using organ-on-a-chip platform, researchers devise potential strategy to treat severe Covid complications
Genomics Australia to guide future of genomic health and medicine over coming decade
Spider silk can stabilise cancer-suppressing protein
Answers for families as researchers identify new rare genetic mutation
Stillbirth and chronic disease link identified in world first discovery
AstraZeneca and Neurimmune close exclusive global collaboration and licence agreement to develop and commercialise NI006
Cell research on rare disease finds new link to inflammation
Shining light on our youngest ovarian cancer patients
Childhood cancer research pioneers backed by Four Diamonds and THON
Novel study to help kids with severe epilepsy
Development of fatty liver disease under healthy diet
TGA Approves NEW Advanced Ovarian Cancer Treatment for Women Living with Deadly Disease
First images of enzyme provide insights into cause of hereditary neurological disease
AstraZeneca and Neurimmune sign exclusive global collaboration and licence agreement to develop and commercialise NI006
Lymphoma cell metabolism may provide new cancer target
AstraZeneca and Ionis close agreement to develop and commercialise eplontersen
AHPPC statement on Omicron public health implications and response options
New approach to analyzing genetics underlying spina bifida